Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Neuroscience Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7970159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease.

  1992cited by this paper
• Pathogenetic basis of vascular dementia.

  1991cited by this paper
• Elevation in relative levels of brain membrane unsaturated fatty acids in Alzheimer's disease: High resolution proton spectroscopic studies of membrane lipid extracts

  1991cited by this paper
• Vitamin E (tocopherols) in human cerebrospinal fluid.

  1991cited by this paper
• Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E.

  1991cited by this paper
• Lipid peroxidation and free radical scavengers in Alzheimer's disease.

  1989cited by this paper
• Inhibition of Oxidation of Biomembranes by Tocopheror a

  1989cited by this paper
• Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls

  1989cited by this paper
• Longitudinal studies of the neurobiology of vitamin E and other antioxidant systems, and neurological function in the vitamin E deficient rat.

  1988cited by this paper
• Determination of alpha-tocopherol and alpha-tocopherylquinone in small biological samples by high-performance liquid chromatography with electrochemical detection.

  1987cited by this paper
• Senile dementia of the Binswanger type. A vascular form of dementia in the elderly.

  1987cited by this paper
• Mitochondrial function in brain tissue in primary degenerative dementia.

  1987cited by this paper
• A receptor-mediated pathway for cholesterol homeostasis.

  1986cited by this paper
• Increased Cerebral Glucose‐6‐Phosphate Dehydrogenase Activity in Alzheimer's Disease May Reflect Oxidative Stress

  1986cited by this paper
• Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type.

  1985cited by this paper
• Concentrations of vitamin E in various neuroanatomical regions and subcellular fractions, and the uptake of vitamin E by specific areas, of rat brain.

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Loss of Ascorbic Acid from Injured Feline Spinal Cord

  1983cited by this paper
• Influence of transient ischemia on lipid-soluble antioxidants, free fatty acids and energy metabolites in rat brain.

  1982cited by this paper
• Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease)

  1978cited by this paper
• Cerebral blood flow in dementia.

  1975cited by this paper
• Subcortical arteriosclerotic encephalopathy. Review of the literature on the so-called Binswanger's disease and presentation of two cases.

  1962cited by this paper

• Fluid biomarkers of vascular cognitive Impairment: From vascular pathophysiology to potential clinical applications.

  2025cites this paper
• The tocopherol transfer protein mediates vitamin E trafficking between cerebellar astrocytes and neurons

  2022cites this paper
• A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases

  2021cites this paper
• Antioxidant action of vitamin E in vivo as assessed from its reaction products with multiple biological oxidants

  2020cites this paper
• Cerebrospinal fluid oxidative stress markers in Alzheimer's disease

  2020cites this paper
• Plasma membrane redox enzymes: new therapeutic targets for neurodegenerative diseases

  2019cites this paper
• The detection of age-, gender-, and region-specific changes in mouse brain tocopherol levels via the application of different validated HPLC methods

  2018cites this paper
• Vitamin E and Alzheimer’s Disease—Is It Time for Personalized Medicine?

  2017influential citation
• Vitamin E for Alzheimer’s dementia and mild cognitive impairment (Review)

  2017cites this paper
• Vitamin E for Alzheimer's dementia and mild cognitive impairment.

  2017cites this paper
• Vitamin E for Alzheimer's dementia and mild cognitive impairment.

  2017cites this paper
• Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses

  2017cites this paper
• A Novel Plasma Based Biomarker of Alzheimer’s Disease

  2015cites this paper
• Effects of Vitamin E on Cognitive Performance during Ageing and in Alzheimer’s Disease

  2014cites this paper
• Kinetic modeling of low density lipoprotein oxidation in arterial wall and its application in atherosclerotic lesions prediction.

  2013cites this paper
• A Possible Role for CSF Turnover and Choroid Plexus in the Pathogenesis of Late Onset Alzheimer's Disease

  2012cites this paper
• Vitamin E for Alzheimer's dementia and mild cognitive impairment.

  2012cites this paper
• Regulation of vitamin E and the tocopherol transfer protein

  2012cites this paper
• Analysis of Postmortem Ventricular Cerebrospinal Fluid from Patients with and without Dementia Indicates Association of Vitamin E with Neuritic Plaques and Specific Measures of Cognitive Performance

  2011cites this paper
• The plasma membrane redox system in Alzheimer's disease.

  2011cites this paper
• Microencapsulated choroid plexus epithelial cell transplants for repair of the brain.

  2010cites this paper
• An update on using vitamin E in Alzheimer's disease

  2008cites this paper
• Apolipoprotein E genotype, vitamin E, and Alzheimer's disease prevention

  2008cites this paper
• Vitamin E for Alzheimer's disease and mild cognitive impairment.

  2008cites this paper
• Total a-Tocopherol Intakes Are Associated with Serum a-Tocopherol Concentrations in African

  2007cites this paper
• Systemic and Brain Metabolic Dysfunction as a New Paradigm for Approaching Alzheimer’s Dementia

  2007cites this paper
• Total alpha-tocopherol intakes are associated with serum alpha-tocopherol concentrations in African American adults.

  2007cites this paper
• Tocopherylquinone and tocopherylhydroquinone

  2007cites this paper
• [Oxidative stress and Alzheimer's disease].

  2006cites this paper
• High Prevalence of Chlamydia Pneumoniae Antibodies and Increased High‐Sensitive C‐Reactive Protein in Patients with Vascular Dementia

  2005influential citation
• Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease

  2005cites this paper
• A role of the choroid plexus in transplantation therapy.

  2005cites this paper
• The choroid plexus in the rise, fall and repair of the brain

  2005cites this paper
• A Role of the Choroid Plexus in Transplantation Therapy

  2005cites this paper
• Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease

  2004cites this paper
• The choroid plexus: function, pathology and therapeutic potential of its transplantation

  2004cites this paper
• Tocopherol (Vitamin E) in Alzheimer’s Disease and Other Neurodegenerative Disorders

  2004cites this paper
• Choroid plexus, aging of the brain, and Alzheimer's disease.

  2003cites this paper
• Antioxidant vitamin intake and risk of Alzheimer disease.

  2003cites this paper
• Vitamin E Stimulates Luteinizing Hormone-Releasing Hormone and Ascorbic Acid Release from Medial Basal Hypothalami of Adult Male Rats1

  2003cites this paper
• Role of Oxidative Stress and Antioxidants in Neurodegenerative Diseases

  2002cites this paper
• Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid.

  2002cites this paper
• Diet-related prevention of Alzheimer's disease: different hypotheses.

  2001cites this paper
• Vitamin E for Alzheimer's disease.

  2000cites this paper
• Association of vitamin E and C supplement use with cognitive function and dementia in elderly men

  2000cites this paper
• Serum Schiff Bases Are Elevated in Patients with Dementia

  2000cites this paper
• Amyloid-ß and Treatment Opportunities for Alzheimer's Disease

  2000cites this paper
• Short Telomeres in Patients with Vascular Dementia: An Indicator of Low Antioxidative Capacity and a Possible Risk Factor?

  2000cites this paper
• Dietary antioxidant intake and cognitive performance in middle-aged adults

  2000cites this paper
• Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations.

  1999cites this paper
• Optimal nutrition: vitamin E

  1999cites this paper
• The cerebrospinal fluid oxidized NO metabolites, nitrite and nitrate, in Alzheimer's disease and vascular dementia of Binswanger type and multiple small infarct type

  1998cites this paper
• [Alzheimer disease, markers in the cerebrospinal fluid. Support of physiopathologic hypotheses].

  1998cites this paper
• Current Status of Antioxidant Therapy for Alzheimer's Disease

  1998cites this paper
• Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes.

  1997cites this paper
• alpha-Tocopherol quinone level is remarkably low in the cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.

  1996cites this paper
• Reduced and oxidized forms of glutathione and alpha-tocopherol in the cerebrospinal fluid of parkinsonian patients: comparison between before and after L-dopa treatment.

  1995cites this paper